RH (RH) reported second quarter adjusted EPS of $0.65 after the close Wednesday, up from $0.44 in the previous year. The consensus estimate was for EPS of $0.47. The company also increased its full year guidance for both revenues and adjusted net income.
Insmed Inc. (INSM) announced Tuesday morning that its Phase 3 study of ALIS in adult patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium Avium Complex met its primary endpoint.
Aerovironment Inc. (AVAV) reported a first quarter loss of $0.19 per share after the bell Tuesday, compared to the loss of $0.51 per share last year. The consensus estimate was for a loss of $0.34 per share. Full year 2018 EPS is expected to be between $0.45 and $0.65. Street expectations are for EPS of $0.56.